The loss of function of tumor protein 53 (P53) (Byers and Rudin, 2015) is almost universal in SCLC patients, as P53 is mutated in over 90% SCLC diagnoses (Wistuba et al., 2001). Here, TP53 is linked to small cell lung carcinoma.